Last reviewed · How we verify
NCT02837861: EMS
Early and Adequate Protein Feeding Post-Traumatic Injury
EARLY_PHASE1 trial testing Routine Nutritional Support plus supplemental IV amino acids in Protein Feeding in Post-traumatic Injury Patients in 45 participants. Completed in 18 October 2019.
18 October 2019
Quick facts
| Lead sponsor | Boston Medical Center |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 45 |
| Start date | 7 March 2017 |
| Primary completion | 18 October 2019 |
| Estimated completion | 18 October 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Routine Nutritional Support plus supplemental IV amino acids — full drug profile →
- Routine Nutritional Support
Conditions studied
- Protein Feeding in Post-traumatic Injury Patients — all drugs for Protein Feeding in Post-traumatic Injury Patients →
Sponsor
Boston Medical Center
Who can join
Adults 18 to 65, any sex, with Protein Feeding in Post-traumatic Injury Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized, parallel-group, pilot study comparing the effect of the early addition of intravenous protein to enteral feeding as tolerated versus enteral feedings as tolerated alone immediately post traumatic injury. Primary: To determine that early and adequate nutritional support will improve protein economy in the first week post -injury as measured by nitrogen balance. We hypothesize that an improvement in nitrogen balance with early maximized protein intake will support the production of acute phase proteins, major antioxidants and the inflammatory response. Secondary: Through the use of mass spectrometry (MS) and nuclear magnetic resonance (NMR) technologies we will determine that our plan for early and adequate nutritional support with adequate protein from day one post injury will alter the metabolomics profile when compared to routine nutritional support. Tertiary: For Specific Aim 3 we will measure several pro- and anti-inflammatory cytokines and soluble proteins.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without supplemental parenteral nutrition in critically ill adults.
Fuentes Padilla P, Martínez G, Vernooij RW, Urrútia G, et al · · 2019 · cited 62× · PMID 31684690 · DOI 10.1002/14651858.cd012340.pub2
Verify or expand the search:
- PubMed search for NCT02837861
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Boston Medical Center trials
Trials by the same sponsor.
- NCT06679114 — Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial · NA · completed
- NCT06093893 — Hypotensive Anesthesia for Orthognathic Surgery · Phase 4 · completed
- NCT06489522 — Parenting Intervention for Mothers With Substance Use Disorder · NA · completed
- NCT05769218 — PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study · NA · recruiting
- NCT06427967 — A Novel Social Emotional Learning Curriculum for Youth With Epilepsy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02837861 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston Medical Center
- Last refreshed: 27 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02837861.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing